Study of the Concentration-effect Relationship of Nivolumab in Patients With Kidney or Lung Cancer

Trial Profile

Study of the Concentration-effect Relationship of Nivolumab in Patients With Kidney or Lung Cancer

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Apr 2018

At a glance

  • Drugs Nivolumab (Primary)
  • Indications Non-small cell lung cancer; Renal cell carcinoma; Squamous cell cancer
  • Focus Therapeutic Use
  • Acronyms NIVEAL
  • Most Recent Events

    • 02 Mar 2018 Planned End Date changed from 1 Feb 2020 to 1 Jan 2020.
    • 02 Mar 2018 Planned primary completion date changed from 1 Feb 2020 to 1 Jan 2020.
    • 02 Mar 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top